首页> 外文期刊>Oncogenesis. >Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner
【24h】

Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner

机译:Erbin的缺乏以STAT3依赖的方式诱导子宫颈癌细胞对凋亡的抵抗

获取原文
           

摘要

Epithelial cell polarization and integration are essential to their function and loss of epithelial polarity and tissue architecture correlates with the development of aggressive tumors. Erbin is a basolateral membrane-associated protein. The roles of Erbin in establishing cell polarization and regulating cell adhesion have been suggested. Erbin is also a negative regulator in Ras-Raf-ERK (extracellular signal-regulated kinase) signaling pathway. However, the potential functions of Erbin in human cancer are basically unknown. In the present study, we show, for the first time, that loss of Erbin endows cervical cancer cells with resistance to anoikis both in vitro and in vivo and promotes the growth and metastasis of human cervical cancer xenografts in nude mice. We found that knockdown of Erbin induced the phosphorylation, nuclear translocation and transcriptional activities of signal transducer and activator of transcription factor 3 (STAT3) in cervical cancer cells. Overexpression of STAT3C or induction of endogenous STAT3 activation by interleukin (IL)-6 evidently inhibited anoikis of cervical cancer cells, whereas WP1066, a potent inhibitor of Janus-activated kinase 2 (Jak2)/STAT3, effectively blocked the effect of Erbin knockdown on cell survival under anchorage-independent conditions, indicating that loss of Erbin confers resistance of cervical cancer cells to anoikis in a STAT3-dependent manner. Interestingly, IL-6 induced STAT3 activation and Erbin expression simultaneously. Overexpression of STAT3C also significantly upregulated the level of Erbin, whereas the Jak2 inhibitor AG490 remarkably blocked not only STAT3 phosphorylation but also IL-6-induced Erbin expression. Knockdown of Erbin augmented the effects of IL-6 on STAT3 activation and anoikis resistance. In addition, by immunohistochemical analysis of Erbin expression, we demonstrate that the expression of Erbin is significantly decreased or even lost in cervical cancer tissues. These data reveal that Erbin is a novel negative regulator of STAT3, and the IL-6/STAT3/Erbin loop has a crucial role in cervical cancer progression and metastasis.
机译:上皮细胞的极化和整合对其功能至关重要,上皮极性和组织结构的丧失与侵袭性肿瘤的发展有关。尔宾是基底外侧膜相关蛋白。已经提出了埃尔宾在建立细胞极化和调节细胞粘附中的作用。 Erbin还是Ras-Raf-ERK(细胞外信号调节激酶)信号传导途径的负调节剂。但是,埃尔宾在人类癌症中的潜在功能基本上是未知的。在本研究中,我们首次表明,Erbin的缺失使子宫颈癌细胞在体外和体内都具有对厌氧症的抵抗力,并促进了裸鼠中人子宫颈癌异种移植物的生长和转移。我们发现敲除Erbin诱导宫颈癌细胞中的信号转导和转录因子3(STAT3)激活剂的磷酸化,核易位和转录活性。 STAT3C的过表达或白介素(IL)-6诱导的内源性STAT3激活明显抑制宫颈癌细胞的失神经,而有效的Janus激活激酶2(Jak2)/ STAT3抑制剂WP1066有效地阻止了Erbin敲低对细胞在不依赖锚定的条件下存活,这表明Erbin的丧失以STAT3依赖性方式赋予子宫颈癌细胞对凋亡的抗性。有趣的是,IL-6同时诱导STAT3激活和Erbin表达。 STAT3C的过表达也显着上调了Erbin的水平,而Jak2抑制剂AG490不仅显着阻断了STAT3磷酸化,还阻断了IL-6诱导的Erbin的表达。击倒Erbin增强了IL-6对STAT3活化和抗阳极氧化的作用。另外,通过对Erbin表达的免疫组织化学分析,我们证明Erbin的表达在宫颈癌组织中显着降低或什至丢失。这些数据表明,Erbin是STAT3的新型负调节剂,而IL-6 / STAT3 / Erbin环在宫颈癌的进展和转移中起着至关重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号